Hims vs SkinnyRx: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Hims beats SkinnyRx overall, scoring 7.9/10 vs 7.3/10. Choose Hims for men who want glp-1 access from a well-known, publicly traded. Choose SkinnyRx for users who want flexibility in compounded glp-1 medication fo.
A side-by-side comparison of Hims and SkinnyRx covering pricing, scores, medication types, insurance, and more to help you decide.
Hims
#12 of 47One of the largest and most recognized men's telehealth platforms in the US. In 2026 Hims signed a direct partnership with Novo Nordisk adding FDA-approved brand Wegovy (injection and pill) and Ozempic alongside their existing compounded semaglutide program.
Visit HimsSkinnyRx
#36 of 47Direct-to-consumer telehealth platform offering compounded GLP-1 medications across five formats — injectable and sublingual semaglutide, semaglutide tablets, and tirzepatide as either injectable or tablets. Operated by Lean Rx, Inc. (Sacramento, CA). Compounded only — does not prescribe brand-name Wegovy/Zepbound/Ozempic/Mounjaro. Cash-pay only with HSA/FSA accepted; does not bill insurance. 4,100+ Trustpilot reviews at 4.8 stars.
Visit SkinnyRx| Feature | Hims | SkinnyRx |
|---|---|---|
| Our Score | 7.9/10 | 7.3/10 |
| Starting Price | $199/mo | $199/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Men who want GLP-1 access from a well-known, publicly traded telehealth brand — now with FDA-approved brand access via the 2026 Novo Nordisk partnership | Users who want flexibility in compounded GLP-1 medication format (injectable, sublingual, or tablet) at a mid-tier price point |
| Ranking | #12 | #36 |
Pros & Cons Compared
Hims
Pros
- +Publicly traded company (NYSE: HIMS) with strong financial backing and regulatory compliance
- +2026 Novo Nordisk partnership — FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims
- +$199/mo all-inclusive for compounded semaglutide with consultations and free shipping
- +Polished app and web experience — one of the best user interfaces in men's telehealth
Cons
- −Brand-name pricing jumps to $599/mo for Wegovy injection — not competitive with LillyDirect/NovoCare cash prices
- −Generic support experience — large patient volume means less personalized attention
- −'Hims Oral Kit' is NOT a GLP-1 (it's a non-GLP-1 combo: metformin + bupropion + topiramate + B12 + naltrexone) — easy to confuse with their compounded semaglutide program
- −Higher price than compounded-only competitors like TrimRx or Enhance MD for the same compounded product
SkinnyRx
Pros
- +Five medication formats — the broadest compounded-GLP-1 menu in DTC telehealth, including the rare oral tirzepatide tablet that almost no competitor offers
- +$199/mo entry price for both injectable and sublingual semaglutide is competitive in the mid-tier compounded segment
- +Fast onboarding: 5–10 minute online questionnaire, physician review in 24–48 hours, medication delivered in 3–7 business days with temperature-controlled shipping
- +4,100+ Trustpilot reviews at 4.8 stars — among the strongest aggregate social-proof signals in the GLP-1 telehealth category
Cons
- −No brand-name FDA-approved options (Wegovy, Zepbound, Ozempic, Mounjaro) — compounded-only model limits patients who want or need an FDA-approved finished product
- −Limited public transparency: founders, executive team, medical director, and specific compounding-pharmacy partners are not named on the public site
- −Cash-pay only — does not bill commercial insurance, Medicare, or Medicaid (HSA/FSA payments accepted)
- −Independent reviews flag inconsistent customer-service responsiveness, which is a real concern for a medication that requires titration support and dose-adjustment dialogue
Our Verdict
Hims edges out SkinnyRx with a score of 7.9/10 vs 7.3/10. Hims offers both brand-name and compounded medications, giving you more flexibility. Choose Hims if you want: men who want glp-1 access from a well-known, publicly traded telehealth brand — now with fda-approved brand access via the 2026 novo nordisk partnership. Choose SkinnyRx if you want: users who want flexibility in compounded glp-1 medication format (injectable, sublingual, or tablet) at a mid-tier price point.